HomeFATE • NASDAQ
add
Fate Therapeutics Inc
Previous close
$1.09
Day range
$1.07 - $1.13
Year range
$0.66 - $2.22
Market cap
128.04M USD
Avg Volume
1.46M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.74M | -43.36% |
Operating expense | 10.64M | -48.86% |
Net income | -32.25M | 32.36% |
Net profit margin | -1.85K | -19.43% |
Earnings per share | -0.27 | 32.50% |
EBITDA | -31.51M | 34.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 215.42M | -27.45% |
Total assets | 343.67M | -30.57% |
Total liabilities | 109.60M | -17.37% |
Total equity | 234.07M | — |
Shares outstanding | 115.35M | — |
Price to book | 0.54 | — |
Return on assets | -24.28% | — |
Return on capital | -26.47% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -32.25M | 32.36% |
Cash from operations | -24.37M | 17.15% |
Cash from investing | 21.27M | -16.45% |
Cash from financing | 2.48M | — |
Net change in cash | -627.00K | 84.16% |
Free cash flow | -13.74M | -3.01% |
About
Founded
2007
Website
Employees
181
